| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TIROFIBAN HYDROCHLORIDE | 206888 | 001 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | No | No | 2021/04/08 | 2021/04/08 | GLAND PHARMA LTD | Prescription |
| TIROFIBAN HYDROCHLORIDE | 213947 | 001 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) | No | No | 2023/02/07 | 2023/02/07 | NEXUS | Prescription |
| TIROFIBAN HYDROCHLORIDE | 213947 | 002 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | No | No | 2023/02/07 | 2023/07/24 | NEXUS | Prescription |
| TIROFIBAN HYDROCHLORIDE | 216379 | 001 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) | No | No | 2023/05/01 | 2023/05/01 | EUGIA PHARMA | Prescription |
| TIROFIBAN HYDROCHLORIDE | 216379 | 002 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | No | No | 2023/05/01 | 2023/05/01 | EUGIA PHARMA | Prescription |
| TIROFIBAN HYDROCHLORIDE | 213947 | 001 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 5MG BASE/100ML (EQ 0.05MG BASE/ML) | No | No | 2023/07/24 | 2023/02/07 | NEXUS | Prescription |
| TIROFIBAN HYDROCHLORIDE | 213947 | 002 | ANDA | TIROFIBAN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | EQ 12.5MG BASE/250ML (EQ 0.05MG BASE/ML) | No | No | 2023/07/24 | 2023/07/24 | NEXUS | Prescription |